T. Rowe Price Associates’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $470K | Buy |
|
|||||
|
2025
Q2 | $404K | Buy |
|
|||||
|
2025
Q1 | $362K | Buy |
|
|||||
|
2024
Q4 | $339K | Buy |
|
|||||
|
2024
Q3 | $269K | Buy |
|
|||||
|
2024
Q2 | $208K | Buy |
|
|||||
|
2024
Q1 | $199K | Buy |
|
|||||
|
2023
Q4 | $243K | Buy |
|
|||||
|
2023
Q3 | $189K | Buy |
|
|||||
|
2023
Q2 | $217K | Buy |
|
|||||
|
2023
Q1 | $208K | Sell |
|
|||||
|
2022
Q4 | $308K | Sell |
|
|||||
|
2022
Q3 | $634K | Sell |
|
|||||
|
2022
Q2 | $659K | Buy |
|
|||||
|
2022
Q1 | $731K | Sell |
|
|||||
|
2021
Q4 | $1.08M | Sell |
|
|||||
|
2021
Q3 | $1.22M | Buy |
|
|||||
|
2021
Q2 | $1.27M | Buy |
|
|||||
|
2021
Q1 | $931K | Sell |
|
|||||
|
2020
Q4 | $679K | Sell |
|
|||||
|
2020
Q3 | $741K | Buy |
|
|||||
|
2020
Q2 | $527K | Sell |
|
|||||
|
2020
Q1 | $6.92M | Buy |
|
|||||
|
2019
Q4 | $10.1M | Buy |
|
|||||
|
2019
Q3 | $10M | Sell |
|
|||||
|
2019
Q2 | $12M | Buy |
|
|||||
|
2019
Q1 | $10.9M | Buy |
|
|||||
|
2018
Q4 | $9.54M | Buy |
|
|||||
|
2018
Q3 | $10.3M | Sell |
|
|||||
|
2018
Q2 | $10.7M | Buy |
|
|||||
|
2018
Q1 | $8.17M | Buy |
|
|||||
|
2017
Q4 | $6.57M | Buy |
|
|||||
|
2017
Q3 | $3.02M | Buy |
|
|||||
|
2017
Q2 | $242K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $157K | Hold |
|
|||||
|
2015
Q2 | $196K | Hold |
|
|||||
|
2015
Q1 | $212K | Hold |
|
|||||
|
2014
Q4 | $227K | Hold |
|
|||||
|
2014
Q3 | $164K | Hold |
|
|||||
|
2014
Q2 | $195K | Hold |
|
|||||
|
2014
Q1 | $188K | Hold |
|
|||||
|
2013
Q4 | $205K | Hold |
|
|||||
|
2013
Q3 | $158K | Hold |
|
|||||
|
2013
Q2 | $135K | Buy |
|